A new cytokine: The possible effect pathway of methionine enkephalin

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 169-173

  Liu, Xin Hua ^a   Huang, Dong Ai ^b   Yang, Fei Yi ^a   Hao, Yan Sheng ^a   Du, Guo Guang ^a   Li, Ping Feng ^a   Li, Gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; DELTA OPIATE RECEPTOR; METENKEPHALIN; MONOCLONAL ANTIBODY; NALOXONE; POLYPEPTIDE; PROTEIN KINASE C;

AMINO ACID SYNTHESIS; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; MYELOMA; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 12244260125     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.169     Document Type: Article

References (30)

1. Peterson PK, Molitor TW, Chao CC. The opioid-cytokine connection. J Neuroimmunology 1998; 83: 63-69
2. Plotnikoff NP, Faith RE, Murgo AJ, Herberman RB, Good RA. Methionine enkephalin: A new cytokine-human studies. Clin Immunol Immunopathol 1997; 82: 93-101
3. Li G, Fraker PJ. Methionine enkephalin alteration of mitogenic and mixed lymphocyte culture responses in zinc-deficient mice. Acta Pharmacol Sin 1989; 10: 216-221
4. Li G, Yu J. Inhibition of bone marrow immature B lymphocytes from zinc deficient mice by methionine enkephalin. Acta Pharmacol Sin 1991; 12: 500-503
5. Kramer HK, Simon EJ. Role of protein kinase C(PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoform of PKC. J Neurochem 1999; 72: 594-604
6. Narita M, Mizoguchi H, Kampine JP, Tseng LF. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br J Pharmacol 1996; 118: 1829-1835
7. Shen J, Benedict GA, Gallagher A, Stafford K, Yoburn BC. Role of camp-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice. Synapse 2000; 38: 322-327
8. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Leibovitch N, Nevo I, Vogel Z. Adenylylcylase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 1995; 270: 29732-29738
9. Liu JG, Anand KJ. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 2001; 38: 1-19
10. Wagner EJ, Ronnekleiv OK, Kelly MJ. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: Convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling. J Pharmacol Exp Ther 1998; 285: 1266-1273
11. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981; 78: 3824-3828
12. Li MS, Li PF, He SP, Du GG, Li G. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J Gastroenterol 2002; 8 469-475
13. Choi SW, Park HY, Rubeiz NG, Sachs D, Gilchrest BA. Protein kinase C-alpha levels are inversely associated with growth rate in cultured human dermal fibroblasts. J Dermatological Sci 1998; 18:54-63
14. Fukuda K, Kato S, Mori K. Location of regions of the opioid receptor involved in selective agonist binding. J Biol Chem 1995; 270: 6702-6709
15. Pepin MC, Yue SY, Roberts E, Wahlestedt C, Walker P. Novel "restoration of function" mutagenesis strategy to identify amino acids of the δ-opioid receptor involved in ligand binding. J Biol Chem 1997; 1272: 9260-9267
16. Meng F, Ueda Y, Hoversten MT, Thompson RC, Taylor L, Watson SJ, Akil H. Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands. Eur J Pharmacol 1996; 311: 285-292
17. Metzger TG, Paterlini M, Ferguson DM, Portoghese PS. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: Exploring the "address" recognition locus. J Med Chem 2001; 44: 857-862
18. Ide S, Sakano K, Seki T, Awamura S, Minami M, Satoh M. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions. Jpn J Pharmacol 2000; 83: 306-311
19. Bonner G, Meng F, Akil H. Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop. Eur J Pharmacol 2000; 403: 37-44
20. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Ann Rev Pharmacol Toxicol 1998; 38: 289-319
21. Whistler JL, Tsao P, Von Zastrow M. A phosphorylation-regulated brake mechanism controls the initial endocytosis of opioid receptors but is not required for post-endocytic sorting to lysosomes. J Biol Chem 2001; 276: 34331-34338
22. Chaturvedi K, Bandari P, Chinen N, Howells RD. Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors. J Biol Chem 2001; 276: 12345-12355
23. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, Loh HH. Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 2000; 275: 32057-32065
24. Kramer HK, Andria ML, Esposito DH, Simon EJ. Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization. Biochem Pharmacol 2000; 60: 781-792
25. Yoshikawa M, Nakayama H, Ueno S, Hirano M, Hatanaka H, Furuya H. Chronic fentanyl treatments induce the up-regulation of mu opioid receptor mRNA in rat pheochromocytoma cells. Brain Res 2000; 859: 217-223
26. Wang Z, Sadee W. Tolerance to morphine at the mu-opioid receptor differentially induced by camp-dependent protein kinase activation and morphine. Eur J Pharmacol 2000; 389: 165-171
27. Roy S, Cain KJ, Chapin RB, Charboneau RG, Barke RA. Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun 1998; 245: 392-396
28. Kramer HK, Simon EJ. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. J Neurochem 1999; 72: 585-593
29. Chakrabarti S, Law PY, Loh HH. Distinct differences between morphine-and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation. J Neurochem 1998; 71: 231-239
30. Sharma P, Kumar Bhardwaj S, Kaur Sandhu S, Kaur G. Opioid regulation of gonadotropin release: Role of signal transduction cascade. Brain Res Bull 2000; 52: 135-142